Personalized Cancer Medicine: Are We There Yet?-Reference-Cited by-同舟云学术

Personalized Cancer Medicine: Are We There Yet?

Published:2013-05-19 Issue:6 Volume:18 Page:649-650
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Lawler Mark¹,Selby Peter²

Affiliation:

1. Centre for Cancer Research and Cell Biology, Queen's University Belfast, Northern Ireland, United Kingdom;

2. Department of Cancer Medicine, University of Leeds, Leeds, United Kingdom

Abstract

Personalized cancer medicine is at a crucial phase of development. This month's edition focuses on how innovation and the development of personalized medicine can positively influence disease outcomes–but at what price?

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2013-0189

Reference7 articles.

1. There are no bad anticancer agents, only bad clinical trial designs—Twenty-first Richard and Hinda Rosenthal Foundation Award Lecture;Hoff;Clin Cancer Res,1998

2. Cancer clinical trials—Do we need a new algorithm in the age of stratified medicine?;Doroshow;The Oncologist,2013

3. Personalized Medicine: Does the Molecular Suit Fit?;Liu;The Oncologist,2013

4. Melanoma in 2011: A new paradigm tumor for drug development;Eggermont;Nat Rev Clin Oncol,2012

5. Perspectives on the development of imatinib and the future of cancer research;Druker;Nat Med,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empowering effective biomarker-driven precision oncology: A call to action;European Journal of Cancer;2024-09

2. Diagnostic and prognostic role of microRNA-525 in different cancers: A systematic review and meta-analysis;2024-02-05

3. Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems;Seminars in Cancer Biology;2021-08

4. Blackboard to Bedside: A Mathematical Modeling Bottom-Up Approach Toward Personalized Cancer Treatments;JCO Clinical Cancer Informatics;2019-12

5. Personalized Medicine, Genomic Profiling and Germline Mutations: Toward More Precise Decisions;Journal of Oncology Practice;2019-09